The recent finding that ZHX2 is a VHL substrate that promotes ccRCC cancer progression by forming a complex with p65 to regulate NF-κB target genes let us to speculate that YAP may target the p65-ZHX2 signaling axis. The gene discussed is NFKB1; the disease is nonpapillary renal cell carcinoma.